Detalhe da pesquisa
1.
Biologically informed deep neural network for prostate cancer discovery.
Nature
; 598(7880): 348-352, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34552244
2.
Reverse chemical ecology approach for the identification of an oviposition attractant for Culex quinquefasciatus.
Proc Natl Acad Sci U S A
; 115(4): 714-719, 2018 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29311316
3.
Genomic Amplification and Functional Dependency of the Gamma Actin Gene ACTG1 in Uterine Cancer.
Int J Mol Sci
; 21(22)2020 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33217970
4.
Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP.
J Virol
; 90(16): 7032-7045, 2016 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27194756
5.
Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens.
J Virol
; 89(5): 2857-65, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25540383
6.
Polyomavirus small T antigen interacts with yes-associated protein to regulate cell survival and differentiation.
J Virol
; 88(20): 12055-64, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25122798
7.
Protein phosphatase 2A isoforms utilizing Aß scaffolds regulate differentiation through control of Akt protein.
J Biol Chem
; 288(44): 32064-73, 2013 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24052256
8.
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.
Mol Cancer Res
; 22(5): 452-464, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38345532
9.
MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer.
bioRxiv
; 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38352340
10.
Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets.
JCO Precis Oncol
; 8: e2300595, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723231
11.
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer.
NPJ Genom Med
; 9(1): 7, 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253539
12.
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.
Prostate Cancer Prostatic Dis
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418892
13.
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies.
Cancer Res Commun
; 4(5): 1369-1379, 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709075
14.
Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC.
Front Oncol
; 13: 1210487, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37456235
15.
Saracatinib synergizes with enzalutamide to downregulate androgen receptor activity in castration resistant prostate cancer.
bioRxiv
; 2023 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163118
16.
Unique Spectrum of Activating BRAF Alterations in Prostate Cancer.
Clin Cancer Res
; 29(19): 3948-3957, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37477913
17.
ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer.
Front Endocrinol (Lausanne)
; 14: 1093332, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37065756
18.
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.
bioRxiv
; 2023 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37577653
19.
ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystems.
Commun Biol
; 6(1): 417, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059746
20.
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma.
Sci Transl Med
; 15(705): eade3341, 2023 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467318